Observational research - Opportunities and limitations

Journal of Diabetes and its Complications

Volumn 27, Issue 6, 2013, Pages 642-648

  Boyko, Edward J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Bias; Causal Inference; Confounding; Epidemiology; Pharmacoepidemiology; Randomized Controlled Trial

Indexed keywords

TROGLITAZONE;

CASE CONTROL STUDY; CLINICAL DECISION MAKING; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; GLYCEMIC CONTROL; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; REVIEW;

BIAS; CAUSAL INFERENCE; CONFOUNDING; EPIDEMIOLOGY; PHARMACOEPIDEMIOLOGY; RANDOMIZED CONTROLLED TRIAL;

BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; CAUSALITY; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; DIABETES MELLITUS; HUMANS; OBSERVATIONAL STUDY AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 84887036209     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2013.07.007     Document Type: Review

References (50)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 36 Suppl 1 2013 S67 S74
2. K. Benson, and A.J. Hartz A comparison of observational studies and randomized, controlled trials The New England Journal of Medicine 342 2000 1878 1886
3. M.V. Boland, and H.P. Lehmann A new method for determining physician decision thresholds using empiric, uncertain recommendations BMC Medical Informatics and Decision Making 10 2010 20
4. M.A. Brookhart, P.S. Wang, D.H. Solomon, and S. Schneeweiss Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable Epidemiology 17 2006 268 275
5. A. Churg Chrysotile, tremolite, and malignant mesothelioma in man Chest 93 1988 621 628
6. J. Concato, N. Shah, and R.I. Horwitz Randomized, controlled trials, observational studies, and the hierarchy of research designs The New England Journal of Medicine 342 2000 1887 1892
7. P. Cummings Propensity scores Archives of Pediatrics & Adolescent Medicine 162 2008 734 737
8. M.J. Cziraky, V.J. Willey, J.M. McKenney, S.A. Kamat, M.D. Fisher, and J.R. Guyton Statin safety: An assessment using an administrative claims database The American Journal of Cardiology 97 2006 61C 68C
9. E.L. Ding, Y. Song, J.E. Manson, D.J. Hunter, C.C. Lee, and N. Rifai Sex hormone-binding globulin and risk of type 2 diabetes in women and men The New England Journal of Medicine 361 2009 1152 1163
10. N.A. DiPietro Methods in epidemiology: Observational study designs Pharmacotherapy 30 2010 973 984
11. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 1998 854 865
12. J. Efird Blocked randomization with randomly selected block sizes International Journal of Environmental Research and Public Health 8 2011 15 20
13. T.R. Fleming, and D.L. DeMets Surrogate end points in clinical trials: Are we being misled? Annals of Internal Medicine 125 1996 605 613
14. E.S. Ford, U.A. Ajani, J.B. Croft, J.A. Critchley, D.R. Labarthe, and T.E. Kottke Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 The New England Journal of Medicine 356 2007 2388 2398
15. C.S. Fox, K. Matsushita, M. Woodward, H.J. Bilo, J. Chalmers, and H.J. Heerspink Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: A meta-analysis Lancet 380 2012 1662 1673
16. C.D. Furberg, and B. Pitt Withdrawal of cerivastatin from the world market Current Controlled Trials in Cardiovascular Medicine 2 2001 205 207
17. T. Gordon, W.B. Kannel, W.P. Castelli, and T.R. Dawber Lipoproteins, cardiovascular disease, and death. The Framingham study Archives of Internal Medicine 141 1981 1128 1131
18. D.A. Grimes, and K.F. Schulz Bias and causal associations in observational research Lancet 359 2002 248 252
19. M.A. Hernan, and J.M. Robins Instruments for causal inference: An epidemiologist's dream? Epidemiology 17 2006 360 372
20. A.B. Hill The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine 58 1965 295 300
21. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 1998 837 853
22. InterAct Consortium Consumption of sweet beverages and type 2 diabetes incidence in European adults: Results from EPIC-InterAct Diabetologia 56 2013 1520 1530
23. W.B. Kannel, P.A. Wolf, J. Verter, and P.M. McNamara Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study Journal of the American Medical Association 214 1970 301 310
24. W.C. Knowler, R.C. Williams, D.J. Pettitt, and A.G. Steinberg Gm3;5,13,14 and type 2 diabetes mellitus: An association in American Indians with genetic admixture American Journal of Human Genetics 43 1988 520 526
25. D.H. Lawson Pharmacoepidemiology: A new discipline British Medical Journal (Clinical Research Ed.) 289 1984 940 941
26. B. Leibel An analysis of the University Group Diabetes Study Program: Data results and conslusions Canadian Medical Association Journal 105 1971 292 294
27. A.D. McMahon, and T.M. MacDonald Design issues for drug epidemiology British Journal of Clinical Pharmacology 50 2000 419 425
28. M.L. Meldrum A brief history of the randomized controlled trial. From oranges and lemons to the gold standard Hematology/Oncology Clinics of North America 14 2000 745 760 vii
29. S.G. Pauker, and J.P. Kassirer The threshold approach to clinical decision making The New England Journal of Medicine 302 1980 1109 1117
30. H. Petri, and J. Urquhart Channeling bias in the interpretation of drug effects Statistics in Medicine 10 1991 577 581
31. R. Pfister, D. Barnes, R. Luben, N.G. Forouhi, M. Bochud, and K.T. Khaw No evidence for a causal link between uric acid and type 2 diabetes: A Mendelian randomisation approach Diabetologia 54 2011 2561 2569
32. C.V. Phillips, and K.J. Goodman The missed lessons of Sir Austin Bradford Hill Epidemiol Perspect Innov 1 2004 3
33. K. Pirie, R. Peto, G.K. Reeves, J. Green, and V. Beral The 21st century hazards of smoking and benefits of stopping: A prospective study of one million women in the UK Lancet 381 2013 133 141
34. C.M. Plasencia, B.W. Alderman, A.E. Baron, R.T. Rolfs, and E.J. Boyko A method to describe physician decision thresholds and its application in examining the diagnosis of coronary artery disease based on exercise treadmill testing Medical Decision Making 12 1992 204 212
35. R.L. Prentice, R. Langer, M.L. Stefanick, B.V. Howard, M. Pettinger, and G. Anderson Combined postmenopausal hormone therapy and cardiovascular disease: Toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial American Journal of Epidemiology 162 2005 404 414
36. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group Journal of the American Medical Association 265 1991 3255 3264
37. B.M. Psaty, N.S. Weiss, C.D. Furberg, T.D. Koepsell, D.S. Siscovick, and F.R. Rosendaal Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease Journal of the American Medical Association 282 1999 786 790
38. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
39. K.J. Rothman, and S. Greenland Causation and causal inference in epidemiology American Journal of Public Health 95 Suppl 1 2005 S144 S150
40. C.L. Roumie, A.M. Hung, R.A. Greevy, C.G. Grijalva, X. Liu, and H.J. Murff Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: A cohort study Annals of Internal Medicine 157 2012 601 610
41. D.B. Rubin Propensity score methods American Journal of Ophthalmology 149 2010 7 9
42. R.R. Rubin, W.Y. Fujimoto, D.G. Marrero, T. Brenneman, J.B. Charleston, and S.L. Edelstein The Diabetes Prevention Program: Recruitment methods and results Controlled Clinical Trials 23 2002 157 171
43. B.R. Shah, A. Laupacis, J.E. Hux, and P.C. Austin Propensity score methods gave similar results to traditional regression modeling in observational studies: A systematic review Journal of Clinical Epidemiology 58 2005 550 559
44. M. Sobek, L. Cleveland, S. Flood, P.K. Hall, M.L. King, and S. Ruggles Big data: Large-scale historical infrastructure from the minnesota population center Hist Methods 44 2011 61 68
45. T. Sturmer, M. Joshi, R.J. Glynn, J. Avorn, K.J. Rothman, and S. Schneeweiss A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods Journal of Clinical Epidemiology 59 2006 437 447
46. D.C. Thomas, and D.V. Conti Commentary: The concept of 'Mendelian Randomization' International Journal of Epidemiology 33 2004 21 25
47. L.F. Tinker, G.E. Sarto, B.V. Howard, Y. Huang, M.L. Neuhouser, and Y. Mossavar-Rahmani Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative American Journal of Clinical Nutrition 94 2011 1600 1606
48. K.J. van Stralen, F.W. Dekker, C. Zoccali, and K.J. Jager Confounding Nephron. Clinical Practice 116 2010 c143 c147
49. S. Wheeler, K. Moore, C.W. Forsberg, K. Riley, J.S. Floyd, and N.L. Smith Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy Diabetologia 2013 2013 Jun 25. [Epub ahead of print]
50. D.K. Wysowski, and L. Swartz Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: The importance of reporting suspected reactions Archives of Internal Medicine 165 2005 1363 1369